Market Overview:
The global wearable injectors market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, technological advancements in wearable injectors, and rising demand for minimally invasive procedures. Based on type, the global wearable injectors market is segmented into electronic injectors and mechanical injectors. The electronic injector segment is expected to grow at a higher CAGR than the mechanical injection segment during the forecast period from 2018 to 2030. This can be attributed to technological advancements in electronic injection devices and their growing adoption for various applications such as cancer, infectious disease, autoimmune disorder, cardiovascular disease, blood disorder etc. Based on application, the global wearable injectors market is divided into five segments: cancer therapy & diagnostics; infectious diseases; autoimmune disorders; cardiovascular diseases; and blood disorders. The cancer therapy & diagnostics application segment accounted for majority share of revenue generated by this market in 2017 and it is projected that this trend will continue during the forecast period from 2018-2030 owing to increasing incidence rates of various types of cancers across globe coupled with rising demand for better treatment options including chemotherapy & radiation therapy which are delivered using portable/wearable devices such as infusion pumps or syringes respectively .
Product Definition:
Wearable injectors are medical devices that allow patients to inject themselves with drugs or other treatments. They are typically small, portable, and easy to use. They can be worn on a belt or in a pocket, and some models include an automatic needle retractor to reduce the risk of accidental injury.
Electronical Injectors:
Electronic injectors are devices that deliver medication through a thin tube by using compressed air or another medium as a propellant. The drug is placed in the injector’s reservoir and then it is propelled into the patient’s body through the injection site by means of an electronic motor.
The global wearable injectors market size was valued at USD 469.1 million in 2016.
Mechanical Injectors:
Mechanical injectors are devices used to deliver medication through the skin using a mechanical system. It is an alternative to traditional methods of injecting drugs such as syringes and vials. The main advantages of mechanical injectors are that they reduce the risk of contamination, there is no need for sterilization, and it allows large doses to be administered quickly with less staff involvement.
The global market for Mechanical Injectors was valued at USD 683 million in 2018.
Application Insights:
The application segment is segregated into seven sub-segments, namely cancer, infectious disease, autoimmune disorder, cardiovascular disease blood disorder, and other diseases. Cancer dominated the market in 2017 owing to increasing prevalence of the disease coupled with a growing number of approvals for new drugs. According to data published by WHO in 2018, an estimated 14.1 million deaths occur every year due to cancer worldwide.
In addition, technological advancements and innovations such as digital technology integration with wearables are expected to boost demand over the forecast period. For instance; In June 2018 Pfizer Inc., a pharmaceutical company collaborated with Apple Inc., Samsung Electronics Co., Ltd., and Fitbit Inc.;to develop software that will allow patients suffering from breast or prostate cancer to track their symptoms using smartwatches or fitness trackers respectively (Fitbit Versa & Fitbit Ionic). Such initiatives by key industry players are expected fuel growth over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of pharmaceutical and medical device manufacturers, coupled with high healthcare expenditure levels in this region, is expected to drive the demand for wearables injectors. In addition, increasing government initiatives to promote patient engagement are also expected to propel the growth of this market over the forecast period. For instance, Health Care Connector (HCC), an initiative by Department Of Health And Human Services (DHHS), promotes electronic health record interoperability across providers and systems through a secure internet connection while protecting patient privacy and data security.
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. Chronic diseases are those that are long-term and cannot be cured completely but can be managed with proper treatment. Some common examples of chronic diseases include diabetes, heart disease, and cancer. Wearable injectors can help in the management of these conditions by providing a continuous supply of medication to the patient over an extended period of time.
- Growing demand for personalized medicine: A major trend in the healthcare industry today is personalized medicine or precision medicine. This approach involves tailoring treatments to specific patients based on their individual genetic makeup or lifestyle factors. One key advantage wearable injectors have over traditional methods is that they can provide very precise doses of medication to patients, thus ensuring better outcomes for them individuallyized care plans .
Scope Of The Report
Report Attributes
Report Details
Report Title
Wearable Injectors Market Research Report
By Type
Electronical Injectors, Mechanical Injectors, Others
By Application
Cancer, Infectious Disease, Autoimmune Disorder, Cardiovascular Disease, Blood Disorder, Others
By Companies
Becton, Dickinson and Company, Medtronic, Johnson & Johnson, Insulet Corporation, Unilife Corporation, Enable Injections, SteadyMed, Ypsomed Group, West Pharmaceutical Services, Becton, CeQur, Sensile Medical, BD Medical, Roche, ScPharmaceuticals, SteadyMed, J & J
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
168
Number of Tables & Figures
118
Customization Available
Yes, the report can be customized as per your need.
Global Wearable Injectors Market Report Segments:
The global Wearable Injectors market is segmented on the basis of:
Types
Electronical Injectors, Mechanical Injectors, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer, Infectious Disease, Autoimmune Disorder, Cardiovascular Disease, Blood Disorder, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Becton
- Dickinson and Company
- Medtronic
- Johnson & Johnson
- Insulet Corporation
- Unilife Corporation
- Enable Injections
- SteadyMed
- Ypsomed Group
- West Pharmaceutical Services
- Becton
- CeQur
- Sensile Medical
- BD Medical
- Roche
- ScPharmaceuticals
- SteadyMed
- J & J
Highlights of The Wearable Injectors Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Electronical Injectors
- Mechanical Injectors
- Others
- By Application:
- Cancer
- Infectious Disease
- Autoimmune Disorder
- Cardiovascular Disease
- Blood Disorder
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Wearable Injectors Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Wearable injectors are devices that can be worn on the body to deliver medications. They are often used to treat chronic conditions such as diabetes, high blood pressure, and heart disease.
Some of the major players in the wearable injectors market are Becton, Dickinson and Company, Medtronic, Johnson & Johnson, Insulet Corporation, Unilife Corporation, Enable Injections, SteadyMed, Ypsomed Group, West Pharmaceutical Services, Becton, CeQur, Sensile Medical, BD Medical, Roche, ScPharmaceuticals, SteadyMed, J & J.
The wearable injectors market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Wearable Injectors Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Wearable Injectors Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Wearable Injectors Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Wearable Injectors Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Wearable Injectors Market Size & Forecast, 2018-2028
4.5.1 Wearable Injectors Market Size and Y-o-Y Growth
4.5.2 Wearable Injectors Market Absolute $ Opportunity
Chapter 5 Global Wearable Injectors Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Wearable Injectors Market Size Forecast by Type
5.2.1 Electronical Injectors
5.2.2 Mechanical Injectors
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Wearable Injectors Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Wearable Injectors Market Size Forecast by Applications
6.2.1 Cancer
6.2.2 Infectious Disease
6.2.3 Autoimmune Disorder
6.2.4 Cardiovascular Disease
6.2.5 Blood Disorder
6.2.6 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Wearable Injectors Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Wearable Injectors Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Wearable Injectors Analysis and Forecast
9.1 Introduction
9.2 North America Wearable Injectors Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Wearable Injectors Market Size Forecast by Type
9.6.1 Electronical Injectors
9.6.2 Mechanical Injectors
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Wearable Injectors Market Size Forecast by Applications
9.10.1 Cancer
9.10.2 Infectious Disease
9.10.3 Autoimmune Disorder
9.10.4 Cardiovascular Disease
9.10.5 Blood Disorder
9.10.6 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Wearable Injectors Analysis and Forecast
10.1 Introduction
10.2 Europe Wearable Injectors Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Wearable Injectors Market Size Forecast by Type
10.6.1 Electronical Injectors
10.6.2 Mechanical Injectors
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Wearable Injectors Market Size Forecast by Applications
10.10.1 Cancer
10.10.2 Infectious Disease
10.10.3 Autoimmune Disorder
10.10.4 Cardiovascular Disease
10.10.5 Blood Disorder
10.10.6 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Wearable Injectors Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Wearable Injectors Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Wearable Injectors Market Size Forecast by Type
11.6.1 Electronical Injectors
11.6.2 Mechanical Injectors
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Wearable Injectors Market Size Forecast by Applications
11.10.1 Cancer
11.10.2 Infectious Disease
11.10.3 Autoimmune Disorder
11.10.4 Cardiovascular Disease
11.10.5 Blood Disorder
11.10.6 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Wearable Injectors Analysis and Forecast
12.1 Introduction
12.2 Latin America Wearable Injectors Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Wearable Injectors Market Size Forecast by Type
12.6.1 Electronical Injectors
12.6.2 Mechanical Injectors
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Wearable Injectors Market Size Forecast by Applications
12.10.1 Cancer
12.10.2 Infectious Disease
12.10.3 Autoimmune Disorder
12.10.4 Cardiovascular Disease
12.10.5 Blood Disorder
12.10.6 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Wearable Injectors Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Wearable Injectors Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Wearable Injectors Market Size Forecast by Type
13.6.1 Electronical Injectors
13.6.2 Mechanical Injectors
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Wearable Injectors Market Size Forecast by Applications
13.10.1 Cancer
13.10.2 Infectious Disease
13.10.3 Autoimmune Disorder
13.10.4 Cardiovascular Disease
13.10.5 Blood Disorder
13.10.6 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Wearable Injectors Market: Competitive Dashboard
14.2 Global Wearable Injectors Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Becton
14.3.2 Dickinson and Company
14.3.3 Medtronic
14.3.4 Johnson & Johnson
14.3.5 Insulet Corporation
14.3.6 Unilife Corporation
14.3.7 Enable Injections
14.3.8 SteadyMed
14.3.9 Ypsomed Group
14.3.10 West Pharmaceutical Services
14.3.11 Becton
14.3.12 CeQur
14.3.13 Sensile Medical
14.3.14 BD Medical
14.3.15 Roche
14.3.16 ScPharmaceuticals
14.3.17 SteadyMed
14.3.18 J & J
